Ribociclib shows potential for pharmacokinetic drug-drug interactions being a substrate of ABCB1 and potent inhibitor of ABCB1, ABCG2 and CYP450 isoforms in vitro
| Autor: | Sorf, Ales a, Hofman, Jakub a, Kučera, Radim b, Staud, Frantisek a, Ceckova, Martina a, ⁎ |
|---|---|
| Zdroj: | In Biochemical Pharmacology August 2018 154:10-17 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect